Amber D. Steele

Array ( [id] => 7121965 [patent_doc_number] => 20050013794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Composition and use' [patent_app_type] => utility [patent_app_number] => 10/850068 [patent_app_country] => US [patent_app_date] => 2004-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11871 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20050013794.pdf [firstpage_image] =>[orig_patent_app_number] => 10850068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7691500 [patent_doc_number] => 20070232533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Use of Vinca Alkaloids and Salts Thereof' [patent_app_type] => utility [patent_app_number] => 10/556309 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8102 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232533.pdf [firstpage_image] =>[orig_patent_app_number] => 10556309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835372 [patent_doc_number] => 20060247203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Freeze-dried preparation containing methylcobalamin and process for producing the same' [patent_app_type] => utility [patent_app_number] => 10/555343 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7053 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247203.pdf [firstpage_image] =>[orig_patent_app_number] => 10555343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7466867 [patent_doc_number] => 20040198776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Methods for increasing leptin levels using nicotinic acid compounds' [patent_app_type] => new [patent_app_number] => 10/825405 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2597 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198776.pdf [firstpage_image] =>[orig_patent_app_number] => 10825405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5194426 [patent_doc_number] => 20070082910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Specific nad(p)h oxidase inhibitor' [patent_app_type] => utility [patent_app_number] => 10/552340 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6518 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082910.pdf [firstpage_image] =>[orig_patent_app_number] => 10552340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5873971 [patent_doc_number] => 20060166208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Induction of the mitochondrial permeability transition' [patent_app_type] => utility [patent_app_number] => 10/534922 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 22886 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166208.pdf [firstpage_image] =>[orig_patent_app_number] => 10534922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10857561 [patent_doc_number] => 08883760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'Cancer therapy using beta glucan and antibodies' [patent_app_type] => utility [patent_app_number] => 10/526185 [patent_app_country] => US [patent_app_date] => 2003-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 49 [patent_no_of_words] => 23078 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10526185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5632374 [patent_doc_number] => 20060148844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation' [patent_app_type] => utility [patent_app_number] => 10/519113 [patent_app_country] => US [patent_app_date] => 2003-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 36247 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148844.pdf [firstpage_image] =>[orig_patent_app_number] => 10519113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4916279 [patent_doc_number] => 20080096880 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Novel use of imidazotriazinones' [patent_app_type] => utility [patent_app_number] => 10/519129 [patent_app_country] => US [patent_app_date] => 2003-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6105 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20080096880.pdf [firstpage_image] =>[orig_patent_app_number] => 10519129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5194430 [patent_doc_number] => 20070082914 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => '4-(4-Methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating pulmonary fibrosis' [patent_app_type] => utility [patent_app_number] => 10/518988 [patent_app_country] => US [patent_app_date] => 2003-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3591 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082914.pdf [firstpage_image] =>[orig_patent_app_number] => 10518988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5194428 [patent_doc_number] => 20070082912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Pyrrole compounds for the treatment of prostaglandine mediated diseases' [patent_app_type] => utility [patent_app_number] => 10/516230 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 118944 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082912.pdf [firstpage_image] =>[orig_patent_app_number] => 10516230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875566 [patent_doc_number] => 20060167109 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Methods of reducing rhinovirus contagion and related compositions' [patent_app_type] => utility [patent_app_number] => 10/504206 [patent_app_country] => US [patent_app_date] => 2003-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12406 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167109.pdf [firstpage_image] =>[orig_patent_app_number] => 10504206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6972334 [patent_doc_number] => 20050038044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Use of propionyl-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie\'s disease' [patent_app_type] => utility [patent_app_number] => 10/496659 [patent_app_country] => US [patent_app_date] => 2002-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7573 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038044.pdf [firstpage_image] =>[orig_patent_app_number] => 10496659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792573 [patent_doc_number] => 20030087917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous system' [patent_app_type] => new [patent_app_number] => 10/239828 [patent_app_country] => US [patent_app_date] => 2002-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9657 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087917.pdf [firstpage_image] =>[orig_patent_app_number] => 10239828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7288357 [patent_doc_number] => 20040147546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Heterocyclic compounds' [patent_app_type] => new [patent_app_number] => 10/475097 [patent_app_country] => US [patent_app_date] => 2004-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 23907 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20040147546.pdf [firstpage_image] =>[orig_patent_app_number] => 10475097 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4553357 [patent_doc_number] => RE041920 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2010-11-09 [patent_title] => 'Isobutylgaba and its derivatives for the treatment of pain' [patent_app_type] => reissue [patent_app_number] => 11/983750 [patent_app_country] => US [patent_app_date] => 1997-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 4035 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/041/RE041920.pdf [firstpage_image] =>[orig_patent_app_number] => 11983750 [rel_patent_id] =>[rel_patent_doc_number] =>)